Home > PS Ratio > NEULAND LABORATORIES

NEULAND LABORATORIES
PS (Price/Sales) Ratio

The Current P/S Ratio of NEULAND LABORATORIES is 5.84.

Share Price ₹7,217.3Apr 24,2024
Market Cap ₹9,238.1 Cr
Sales-TTM₹1,580.6 CrTTM-Consolidated Results
Price/Sales5.84xCalculated as Market Cap/Sales
Explore Stock Analytics
COMMUNITY POLL
for NEULAND LABORATORIES
Please provide your vote to see the results
NEULAND LABORATORIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals

Definition & Calculation of PS (Price/Sales) ratio of NEULAND LABORATORIES

Price-to-Sales ratio, P/S Multiple, or P/S Ratio is an important valuation multiple that is defined as:

P/S = Market Capitalization / Sales

or, using per-share numbers:

P/S = Stock Price / Sales Per Share

Applying the above formula, P/S ratio of NEULAND LABORATORIES is calculated as :

Current Market Cap [ ₹9,238.1 Cr] as on Apr 24,2024

(/) Sales [ ₹1,580.6 Cr] based on TTM-Consolidated Results

(=) P/S Ratio [ 5.84x ]

P/S Ratio indicates 'the multiple of sales' investors are willing to pay to own one share of the company.

Thus, for NEULAND LABORATORIES , the investors are currently willing to pay '5.84 times sales' to own 1 share of the company.

PS Multiples are one of the most widely used valuation multiple in the industry.

P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.

You may also explore Price to Earnings ratio or Price to Book ratio of NEULAND LABORATORIES !

The chart below summarizes the trend in P/S Ratio of NEULAND LABORATORIES over the last five years.

Historical PS (Price/Sales) ratio chart of NEULAND LABORATORIES


PS Ratio Performance Analysis for NEULAND LABORATORIES

- NEULAND LABORATORIES 's latest p/e ratio is 5.84x.

- NEULAND LABORATORIES 's p/e ratio for fiscal years ending Mar2023 to Mar2019 averaged 1.59x.

- NEULAND LABORATORIES 's operated at median p/e ratio of 1.38x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, NEULAND LABORATORIES 's p/e ratio peaked in Mar2021 at 2.86x.

- NEULAND LABORATORIES 's p/e ratio hit its five-year low in Mar2020 of 0.48x.


How does NEULAND LABORATORIES 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Sales (Cr)PS RatioMarket Cap (Cr)
NEULAND LABORATORIES 1,580.65.849,238.1
SUN PHARMACEUTICAL INDUSTRIES LTD47,444.67.52356,625.0
CIPLA LTD25,350.24.46112,938.0
DR REDDYS LABORATORIES LTD27,212.53.6599,276.9
ZYDUS LIFESCIENCES LTD19,024.24.9493,921.9
DIVIS LABORATORIES LTD7,492.813.52101,315.0
MANKIND PHARMA LTD9,946.39.6796,143.2
TORRENT PHARMACEUTICALS LTD10,474.08.6890,872.6
LUPIN LTD19,480.13.7072,010.8
AUROBINDO PHARMA LTD27,894.72.2863,492.3
ABBOTT INDIA LTD5,753.49.4054,105.4

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs NEULAND LABORATORIES 's P/S Ratio

Top 10 Industry PeersPS Ratio
Min industry PS 2.28x
Max industry PS 13.52x
Median industry PS 5.84x
Average industry PS 6.69x



You may also like the below Video Courses